Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants
about
Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse TranscriptaseResistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720Differential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strainsThe nucleoside analog-resistant E89G mutant of human immunodeficiency virus type 1 reverse transcriptase displays a broader cross-resistance that extends to nonnucleoside inhibitorsGenotypic testing for human immunodeficiency virus type 1 drug resistance.The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.In search of a selective antiviral chemotherapy.Effect of mutations at position E138 in HIV-1 reverse transcriptase and their interactions with the M184I mutation on defining patterns of resistance to nonnucleoside reverse transcriptase inhibitors rilpivirine and etravirine.HIV-1 Protease and reverse-transcriptase mutations: correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillanceThe Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.TMC125 displays a high genetic barrier to the development of resistance: evidence from in vitro selection experiments.Characterization of novel non-nucleoside reverse transcriptase (RT) inhibitor resistance mutations at residues 132 and 135 in the 51 kDa subunit of HIV-1 RT.Antiviral activity of 4-benzyl pyridinone derivatives as HIV-1 reverse transcriptase inhibitors.
P2860
Q27676777-2644846F-9FCE-4D1E-BC0A-B3F4881B9F67Q28367603-2A22750A-D9CB-49AD-9548-0292242D8542Q28367707-3AF4A181-9059-476F-91BD-DA2B5633C38AQ28379139-0C14BEA4-63CC-48C4-AD70-6AD5E4027D75Q33906239-49024EA4-E206-425F-8BA9-FFCB6733BE7AQ35123663-AF75FBE3-39C5-4A33-9B55-5BBD063BAF2EQ35375912-0D55595F-B4E1-41E6-BFCB-33BDE4083E13Q36969977-BF91C0DF-C6DC-4275-BCDD-F83330274228Q37003252-DCB66889-2690-4F3D-B885-FE48266EB541Q37018369-6A137937-72EA-4A64-ADCA-8565B0B7C79FQ39699409-5A8F752F-34CA-412C-BC3D-CC462B556C2CQ42033549-07D2AE94-0C6B-4F13-B421-0E86172440A0Q42179793-2693494F-4245-4733-BC98-7588AE1B8728Q46576605-F0C7046A-6ACB-4FD9-830A-2B921BEB29E6
P2860
Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants
description
1994 nî lūn-bûn
@nan
1994 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@ast
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@nl
type
label
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@ast
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@nl
prefLabel
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@ast
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@nl
P2093
P2860
P50
P356
P1476
Human immunodeficiency virus 1 ...... Y181C-->C181I)RT HIV-1 mutants
@en
P2093
M J Camarasa
V V Sardana
P2860
P304
P356
10.1073/PNAS.91.14.6599
P407
P577
1994-07-05T00:00:00Z